創美藥業：2024年年度報告.pdf

1、2024年度報告ANNUAL REPORT於中華人民共和國註冊成立之股份有限公司A joint stock limited liability company established in the Peoples Republic of China -001-年度报告年度报告 ANNUAL REPORT 2024 創美藥業股份有限公司（股份代號：2289.HK）主營醫藥分銷業務，主要向下游分銷商和零售終端分銷西藥、中成藥、保健品等產品，同時也開展第三方物流服務，並提供醫藥產品諮詢服務。本公司創立於 2000 年，經過 25 年的快速發展，已成長為華南地區領先的醫藥分銷商之一。本公司堅持深耕廣東

2、，輻射周邊的發展戰略，立足於汕頭，在廣州、珠海、惠州、佛山及深圳成立子公司，並擁有四個現代化醫藥物流中心，專業的營銷服務團隊以及運輸服務團隊，對非招標市場實行半徑 10 公里內一日三配、50 公里內一日兩配、250 公里內一日一配的高效配送機制。本公司具有現代化信息系統，涵蓋整個醫藥分銷供應鏈，包括採購、銷售、倉儲、運輸及交付等。本公司同時運營自建的 B2B 電子商務平台：創美 e 藥，供客戶線上下單、查詢及支付等。本公司於 2023 年全國批發企業主營業務收入前100位排序35。本公司於廣東省醫藥流通企業排名第6 位。Charmacy Pharmaceutical Co.,Ltd.(stoc

3、k code:2289.HK)is principally engaged in the pharmaceutical distribution business.It mainly distributes western medicine,Chinese patent medicine and healthcare products to downstream distributors and retail terminals,while conducting dealings in the third-party logistics business of medicines and pr

4、oviding pharmaceutical products related consulting services.Founded in 2000,over the past 25 years of rapid development,it has become one of the leading pharmaceutical distributors in the Southern China region.The Company adheres to the development strategy of“Intensive Engagement in Guangdong Provi

5、nce and Extensive Coverage across Surrounding Areas”,based in Shantou,it has established subsidiaries in Guangzhou,Zhuhai,Huizhou,Foshan and Shenzhen,and has four modern pharmaceutical logistics centers.,all equipped with Professional marketing service team,professional transportation teams,and has

6、a highly efficient delivery mechanism of delivering pharmaceutical products three times per day for customers within a radius of 10 kilometers,twice per day for customers within a radius of 50 kilometers and once per day for those within a radius of 250 kilometers.In addition,the Company has a moder